4//SEC Filing
de Craecker Francoise 4
Accession 0001628280-21-020185
CIK 0001501697other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:15 PM ET
Size
5.6 KB
Accession
0001628280-21-020185
Insider Transaction Report
Form 4
de Craecker Francoise
Director
Transactions
- Award
Stock Option (right to buy)
2021-10-14+12,250→ 12,250 totalExercise: $5.37Exp: 2031-10-13→ Common Stock (12,250 underlying)
Footnotes (1)
- [F1]33.3333% of the shares subject to the option shall vest on October 14, 2022, with the remainder vesting thereafter in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001887843
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:15 PM ET
- Size
- 5.6 KB